GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Byotrol PLC (LSE:BYOT) » Definitions » Valuation Rank

Byotrol (LSE:BYOT) Valuation Rank


View and export this data going back to 2005. Start your Free Trial

What is Byotrol Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Byotrol Valuation Rank Related Terms

Thank you for viewing the detailed overview of Byotrol's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Byotrol (LSE:BYOT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Byotrol PLC (LSE:BYOT) » Definitions » Valuation Rank
Comparable Companies
LSE:CLAI PG XPAR:OR LSE:ULVR CL BOM:500696 EL KMB LSE:RKT KVUE XTER:BEI XTER:HEN3 XAMS:DSFIR CHD TSE:4452 CLX XSWX:GALD OSTO:ESSITY B TSE:8113 BOM:532424
Traded in Other Exchanges
B7Y:Germany
Address
Building 303 (Ashton), Pool Lane, Thornton Science Park, Ince, Chester, GBR, CH2 4NU
Website
https://www.byotrolplc.com
Byotrol PLC is a developer of consumer and professional antimicrobial technologies and products. It is engaged in the development, patenting, licensing, and sale of anti-microbial products and technologies for business and consumer use. It operates in two reportable segments, being Professional (including Human Health, Animal Health, Facilities Management, and Food & Beverage), and Consumer (Including Household, Skin Care, and Pet Care). Its customers are based in the UK, North America, Asia, and the Rest of the World. The company generates key revenue from product sales - sale of anti-microbial technology and includes Royalty and licensing income.